Literature DB >> 3706377

Disseminated atypical mycobacterial infection in patients with hairy cell leukemia.

C Bennett, J Vardiman, H Golomb.   

Abstract

Disseminated atypical mycobacterial infections developed in nine of 186 patients with hairy cell leukemia who were seen over 10 years at the University of Chicago Hospital. Clinically, these patients had symptoms of fever and chills; an infiltrate was usually present on chest radiography. Invasive diagnostic studies, including thoracotomy and laparotomy, were necessary for confirmation of the diagnosis of atypical mycobacteria infection. Confirmatory culture specimens were obtained from lymph nodes, liver, and splenic tissue. Six patients had infections with Mycobacterium kansasii; two with M. avium-intracellulare; and one with M. chelonei. Treatment with multiple anti-tuberculosis drugs was initiated either empirically (six patients); after obtaining pathologic evidence of granuloma or acid-fast bacilli (two patients); or after obtaining a positive culture result (one patient). Five of the nine patients survived the infection and continued taking anti-tuberculosis drugs for total periods of nine months to two years. Awareness of the association between hairy cell leukemia and atypical mycobacteria infection, with early consideration of invasive diagnostic studies, as well as empiric anti-tuberculosis therapy, may prolong the survival time for many patients with hairy cell leukemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3706377     DOI: 10.1016/0002-9343(86)90634-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

Review 1.  Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.

Authors:  Sang Hoon Han; Kyoung Min Kim; Bum Sik Chin; Suk Hoon Choi; Han Sung Lee; Myung Soo Kim; Su Jin Jeong; Hee Kyoung Choi; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

2.  Cerebral tuberculomas in a patient with hairy cell leukaemia treated with cladribine.

Authors:  Samuel Barbosa Fonseca; Júlio Rodrigues de Oliveira; Cristina Gonçalves; Virgínia Lopes
Journal:  BMJ Case Rep       Date:  2016-12-07

Review 3.  Hairy cell leukemia: clinical features and therapeutic advances.

Authors:  B C Lembersky; H M Golomb
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Atypical mycobacterial infection in hairy cell leukemia treated with cladribine.

Authors:  Chandramohan Ramasamy; Biswajit Dubashi; J Sree Rekha; Debdatta Basu; Ankit Jain; Tarun Kumar Dutta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-09       Impact factor: 0.900

5.  Mycotic aneurysm and disseminated Mycobacterium avium-intracellulare infection in a patient with hairy cell leukemia.

Authors:  D C Dugdale; D L Stevens; L L Knight
Journal:  West J Med       Date:  1989-02

6.  Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.

Authors:  Jana P Lovell; Christa S Zerbe; Kenneth N Olivier; Reginald J Claypool; Cathleen Frein; Victoria L Anderson; Alexandra F Freeman; Steven M Holland
Journal:  Ann Am Thorac Soc       Date:  2016-12

Review 7.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 8.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

9.  Nontuberculous mycobacterial infection in HIV-negative patients receiving immunosuppressive therapy.

Authors:  K Skogberg; P Ruutu; P Tukiainen; V V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 10.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.